NPPB and pulmonary arterial hypertension: Zhu et al. have found that ligustrazine not only has a good effect of dilating arteries and reducing the pulmonary arterial pressure of PAH patients but also has an antioxidant effect to scavenge oxygen free radicals and reduce the NT-proBNP level [24].